Brief: Innate Pharma FY Basic EPS EUR -0.09
21/03/2024 06:04
Mar 21 (Reuters) - Innate Pharma FY basic EPS EUR -0.09. * FY operating expenses EUR -74.31 million * FY net income continuing operations EUR -7.57 million * FY EPS continuing operations EUR -0.09 * FY operating income EUR -12.669 million * FY adjusted operating income EUR -12.669 million
Recent news on Innate Pharma SA
See all newsFrance's Innate Pharma posts lower 2025 revenue as key contracts decline
Brief: Innate Pharma FY Operating Expenses EUR -63.013 Million
Brief: Innate Pharma Sa Says Sanofi to invest up to 15 million Euros In Innate Pharma
Brief: Innate Pharma Says Jonathan Dickinson To Be Appointed CEO And Board Member
French and Benelux stocks-Factors to watch